Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10,973 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Results of a randomised, controlled, multicentre study of recombinant human granulocyte colony-stimulating factor (filgrastim) in patients with Hodgkin's disease and non-Hodgkin's lymphoma undergoing autologous bone marrow transplantation.
Schmitz N, Dreger P, Zander AR, Ehninger G, Wandt H, Fauser AA, Kolb HJ, Zumsprekel A, Martin A, Hecht T. Schmitz N, et al. Among authors: martin a. Bone Marrow Transplant. 1995 Feb;15(2):261-6. Bone Marrow Transplant. 1995. PMID: 7539668 Clinical Trial.
Durable benefit of rituximab maintenance post-autograft in patients with relapsed follicular lymphoma: 12-year follow-up of the EBMT lymphoma working party Lym1 trial.
Pettengell R, Uddin R, Boumendil A, Johnson R, Metzner B, Martín A, Romejko-Jarosinska J, Bence-Bruckler I, Giri P, Niemann CU, Robinson SP, Kimby E, Schmitz N, Dreger P, Goldstone AH, Montoto S. Pettengell R, et al. Among authors: martin a. Bone Marrow Transplant. 2021 Jun;56(6):1413-1421. doi: 10.1038/s41409-020-01182-w. Epub 2021 Jan 15. Bone Marrow Transplant. 2021. PMID: 33452448 Clinical Trial.
Clinical significance of CD34+ cell dose in long-term engraftment following autologous peripheral blood stem cell transplantation.
Pérez-Simón JA, Martín A, Caballero D, Corral M, Nieto MJ, Gonzalez M, Vazquez L, López-Berges C, Cañizo MC, Mateos MV, Orfao A, San Miguel JF. Pérez-Simón JA, et al. Among authors: martin a. Bone Marrow Transplant. 1999 Dec;24(12):1279-83. doi: 10.1038/sj.bmt.1702066. Bone Marrow Transplant. 1999. PMID: 10627635 Clinical Trial.
Usefulness of eltrombopag for treating thrombocytopenia after allogeneic stem cell transplantation.
Rivera D, Bastida JM, Lopez-Corral L, Sanchez-Guijo F, Cabrero M, Martin A, Perez E, Lopez-Parra M, Avendaño A, Veiga A, Baile M, Arratibel N, Carrillo J, Vazquez L, Caballero MD, Gonzalez-Porras JR. Rivera D, et al. Among authors: martin a. Bone Marrow Transplant. 2019 May;54(5):757-761. doi: 10.1038/s41409-018-0368-1. Epub 2018 Oct 24. Bone Marrow Transplant. 2019. PMID: 30356164 Clinical Trial. No abstract available.
Total body irradiation versus thiotepa/busulfan-based conditioning regimens for myeloablative allogeneic stem cell transplantation in adults with acute lymphoblastic leukemia.
Mora E, Montoro J, Balaguer A, Rovira M, Cabrero M, Heras I, Ribera JM, Antelo G, Martin AA, Lopez Godino O, Torrent A, Villalba M, Chorao P, Sanz MA, Sanz J; Grupo Español de Trasplante Hematopoyético (GETH). Mora E, et al. Among authors: martin aa. Bone Marrow Transplant. 2024 Aug;59(8):1137-1145. doi: 10.1038/s41409-024-02298-z. Epub 2024 May 16. Bone Marrow Transplant. 2024. PMID: 38755458
10,973 results
You have reached the last available page of results. Please see the User Guide for more information.